154 related articles for article (PubMed ID: 34674925)
1. Oncostatin M sensitizes keratinocytes to UVB-induced inflammation via GSDME-mediated pyroptosis.
Liu J; Zhong Y; Liu H; Yang H; Lu P; Shi Y; Wang X; Zheng W; Yu X; Xu Y; Yang B
J Dermatol Sci; 2021 Nov; 104(2):95-103. PubMed ID: 34674925
[TBL] [Abstract][Full Text] [Related]
2. AHNAK, regulated by the OSM/OSMR signaling, involved in the development of primary localized cutaneous amyloidosis.
Liu H; Qiu B; Yang H; Zheng W; Luo Y; Zhong Y; Lu P; Chen J; Luo Y; Liu J; Yang B
J Dermatol Sci; 2023 May; 110(2):53-60. PubMed ID: 37100691
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M.
Yu Z; Li Z; Wang C; Pan T; Chang X; Wang X; Zhou Q; Wu X; Li J; Zhang J; Liu B; Zhu Z; Su L
Gastric Cancer; 2019 Sep; 22(5):955-966. PubMed ID: 30778797
[TBL] [Abstract][Full Text] [Related]
4. GSDME deficiency leads to the aggravation of UVB-induced skin inflammation through enhancing recruitment and activation of neutrophils.
Chen Y; Lian N; Chen S; Xiao T; Ke Y; Zhang Y; Song C; Yang Y; Xu S; Gu H; Chen X
Cell Death Dis; 2022 Oct; 13(10):841. PubMed ID: 36182937
[TBL] [Abstract][Full Text] [Related]
5. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
[TBL] [Abstract][Full Text] [Related]
6. Gasdermin E permits interleukin-1 beta release in distinct sublytic and pyroptotic phases.
Zhou B; Abbott DW
Cell Rep; 2021 Apr; 35(2):108998. PubMed ID: 33852854
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M upregulates Livin to promote keratinocyte proliferation and survival via ERK and STAT3 signalling pathways.
Wang H; Lei L; Hu J; Li Y
Exp Physiol; 2020 Jul; 105(7):1151-1158. PubMed ID: 32359099
[TBL] [Abstract][Full Text] [Related]
8. Reduction of miR-133a-3p contributes to apoptosis and gasdermin E-mediated pyroptosis of keratinocytes in skin exposed to ultraviolet B radiation.
Song C; Zhang W; Xiao T; Li M; Zhang Y; Wei X; Chen Y; Lian N; Ke Y; Yu H; Li M; Gu H; Chen X
J Photochem Photobiol B; 2023 Jan; 238():112613. PubMed ID: 36495669
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
[TBL] [Abstract][Full Text] [Related]
10. Oncostatin M can sensitize sensory neurons in inflammatory pruritus.
Tseng PY; Hoon MA
Sci Transl Med; 2021 Nov; 13(619):eabe3037. PubMed ID: 34757808
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M pathway plays a major role in the renal acute phase response.
Luyckx VA; Cairo LV; Compston CA; Phan WL; Mueller TF
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F875-83. PubMed ID: 19158344
[TBL] [Abstract][Full Text] [Related]
12. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.
Elks CM; Zhao P; Grant RW; Hang H; Bailey JL; Burk DH; McNulty MA; Mynatt RL; Stephens JM
J Biol Chem; 2016 Aug; 291(33):17066-76. PubMed ID: 27325693
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation.
Boniface K; Diveu C; Morel F; Pedretti N; Froger J; Ravon E; Garcia M; Venereau E; Preisser L; Guignouard E; Guillet G; Dagregorio G; Pène J; Moles JP; Yssel H; Chevalier S; Bernard FX; Gascan H; Lecron JC
J Immunol; 2007 Apr; 178(7):4615-22. PubMed ID: 17372020
[TBL] [Abstract][Full Text] [Related]
14. Famotidine promotes inflammation by triggering cell pyroptosis in gastric cancer cells.
Huang J; Fan P; Liu M; Weng C; Fan G; Zhang T; Duan X; Wu Y; Tang L; Yang G; Liu Y
BMC Pharmacol Toxicol; 2021 Oct; 22(1):62. PubMed ID: 34686215
[TBL] [Abstract][Full Text] [Related]
15. Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma.
Kucia-Tran JA; Tulkki V; Scarpini CG; Smith S; Wallberg M; Paez-Ribes M; Araujo AM; Botthoff J; Feeney M; Hughes K; Caffarel MM; Coleman N
J Pathol; 2018 Mar; 244(3):283-295. PubMed ID: 29205362
[TBL] [Abstract][Full Text] [Related]
16. Effects of amyloid β (Aβ)42 and Gasdermin D on the progression of Alzheimer's disease
Hong W; Hu C; Wang C; Zhu B; Tian M; Qin H
Aging (Albany NY); 2023 Nov; 15(21):12209-12224. PubMed ID: 37921870
[TBL] [Abstract][Full Text] [Related]
17. Dihydromyricetin inhibits NLRP3 inflammasome-dependent pyroptosis by activating the Nrf2 signaling pathway in vascular endothelial cells.
Hu Q; Zhang T; Yi L; Zhou X; Mi M
Biofactors; 2018 Mar; 44(2):123-136. PubMed ID: 29193391
[TBL] [Abstract][Full Text] [Related]
18. The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice.
Adrian-Segarra JM; Sreenivasan K; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 Dec; 293(52):20181-20199. PubMed ID: 30373773
[TBL] [Abstract][Full Text] [Related]
19. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation.
Wang Z; Zhou H; Zheng H; Zhou X; Shen G; Teng X; Liu X; Zhang J; Wei X; Hu Z; Zeng F; Hu Y; Hu J; Wang X; Chen S; Cheng J; Zhang C; Gui Y; Zou S; Hao Y; Zhao Q; Wu W; Zhou Y; Cui K; Huang N; Wei Y; Li W; Li J
Autophagy; 2021 Feb; 17(2):529-552. PubMed ID: 32019420
[TBL] [Abstract][Full Text] [Related]
20. Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas.
Chen D; Chu CY; Chen CY; Yang HC; Chiang YY; Lin TY; Chiang IP; Chuang DY; Yu CC; Chow KC
J Pathol; 2008 Jul; 215(3):290-9. PubMed ID: 18491353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
